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Background: While Deep Brain Stimulation (DBS) of the Globus pallidus internus is a
well-established therapy for idiopathic/genetic dystonia, benefits for acquired dystonia
are varied, ranging from modest improvement to deterioration. Predictive biomarkers to
aid DBS prognosis for children are lacking, especially in acquired dystonias, such as
dystonic Cerebral Palsy. We explored the potential role of machine learning techniques
to identify parameters that could help predict DBS outcome.
Methods: We conducted a retrospective study of 244 children attending King’s College
Hospital between September 2007 and June 2018 for neurophysiological tests as part
of their assessment for possible DBS at Evelina London Children’s Hospital. For the 133
individuals who underwent DBS and had 1-year outcome data available, we assessed
the potential predictive value of six patient parameters: sex, etiology (including cerebral
palsy), baseline severity (Burke-Fahn-Marsden Dystonia Rating Scale-motor score),
cranial MRI and two neurophysiological tests, Central Motor Conduction Time (CMCT)
and Somatosensory Evoked Potential (SEP). We applied machine learning analysis to
determine the best combination of these features to aid DBS prognosis. We developed
a classification algorithm based on Decision Trees (DTs) with k-fold cross validation for
independent testing. We analyzed all possible combinations of the six features and
focused on acquired dystonias.
Results: Several trees resulted in better accuracy than the majority class classifier.
However, the two features that consistently appeared in top 10 DTs were CMCT
and baseline dystonia severity. A decision tree based on CMCT and baseline
severity provided a range of sensitivity and specificity, depending on the threshold
chosen for baseline dystonia severity. In situations where CMCT was not available,
a DT using SEP alone provided better than the majority class classifier accuracy.
Shah et al. Childhood-Dystonia: Data-Driven DBS Prognosis
Conclusion: The results suggest that neurophysiological parameters can help predict
DBS outcomes, and DTs provide a data-driven, highly interpretable decision support
tool that lends itself to being used in clinical practice to help predict potential benefit of
DBS in dystonic children. Our results encourage the introduction of neurophysiological
parameters in assessment pathways, and data collection to facilitate multi-center
evaluation and validation of these potential predictive markers and of the illustrative
decision support tools presented here.
Keywords: dystonia, machine learning, deep brain stimulation, decision support systems, decision trees
INTRODUCTION
Deep Brain Stimulation (DBS) of the Globus pallidus internus
(GPi) is a well-established management for isolated idiopathic
or genetic dystonia both in adults (1–4) and children (5).
In childhood, acquired dystonias are more common than
idiopathic/genetic dystonias, comprising ∼80% of patients
referred for consideration of DBS (5). There are many reports
of successful outcomes in acquired dystonias, but benefits
are generally more modest and the variability in outcome is
much greater than in idiopathic/genetic dystonias (1, 4, 6).
Studies of DBS for acquired dystonia are sparse and generally
limited to small numbers. For example, a recent meta-analysis
and systematic review of DBS for childhood dystonia yielded
individual patient data from a total of only 125 patients with
acquired dystonia across 72 articles (7, 8).
Appropriate family counseling is essential to manage
expectations before a young person undergoes functional
neurosurgery, which is not without risk (9, 10) but predictive
markers of DBS outcomes in acquired and complex dystonias are
lacking (11) and families are asking for more information to help
guide this decision (12, 13).
We have previously reported a relationship between
neurophysiological measures of corticospinal tract and sensory
pathway integrity and outcome from DBS in a group of children
and young people with dystonia (or dystonia-dyskinesia) (6). In
that study, abnormalities of either Central Motor Conduction
Time (CMCT) or Somatosensory Evoked Potentials (SEP)
were associated with less reduction in dystonia at one-year
follow-up, as measured using the Burke-Fahn-Marsden Dystonia
Rating Scale-motor score (BFMDRS-m) and (for SEPs) using
the Canadian Occupational Performance Measure (COPM)
(6, 13). This was the first study to investigate the role of
neurophysiological tools as potential predictive markers which
could help to guide counseling of families (6). However, there
were a number of limitations: in particular, although the overall
sample was large, the numbers of children with abnormal CMCT
and/or SEP who proceeded to DBS and already had 1-year
outcome data were small. The current study builds on this
previous work by reporting findings from a larger group of
young people and by leveraging techniques developed in the
machine learning community to investigate the most optimal
clinical decision tool that synthesizes various clinical features
and assesses their accuracy in predicting outcomes.
METHODS
Data were reviewed retrospectively from all 244 children with
medically refractory dystonia who attended King’s College
Hospital between September 2007 and June 2018 for CMCT
and/or SEPs as part of their assessment for possible pallidal Deep
Brain Stimulation via the Complex Motor Disorders Service
at Evelina London Children’s Hospital. This was an extension
of a previously published dataset (6) comprising 180 children.
The neurophysiological studies were performed as part of a
standard clinical work-up, along with detailed imaging and a
multi-disciplinary clinical assessment by a pediatric neurologist,
nurse specialist, physiotherapist, occupational therapist,
speech and language therapist and clinical neuropsychologist.
Ethical approval for the retrospective analysis was obtained
(London-Harrow National Research Ethics Committee, London,
UK (17/LO/0439).
Data Acquisition
The young people were examined by a consultant pediatric
neurologist with expertise in movement disorders (JPL) and
dystonia was classified in line with the Albanese dystonia
classification (14), taking into account the clinical characteristics
and etiology (Table 1). Baseline dystonia severity was assessed
using the BFMDRS-m. For those proceeding to DBS (n = 133),
outcome was expressed as percentage improvement in BFMDRS-
m from baseline to 1 year post-operatively. The Canadian
Occupational Performance Measure (COPM) was used as an
additional outcome measure (13), although was not available in
all patients.
CMCT was assessed using Transcranial Magnetic Stimulation
(TMS) and the F-wave method and interpreted in relation
to established norms, as published previously (6, 15). CMCT
reaches adult values by age 3 years for upper limbs (16) and by age
6 years for lower limbs (17). A CMCT was considered abnormal
if it was prolonged or the MEP to that limb was absent. For the
purposes of statistical analysis, any cases in whom a prolonged
CMCT was obtained which could have been physiological, due
to immaturity, were excluded from the analysis [see (15) for
discussion]. Some children with high MEP thresholds were
unable to tolerate the stimulus to high enough intensity to
determine whether a normal latency MEP was present. These
data were excluded along with any other traces which were
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TABLE 1 | Distribution of patients across different etiological groups.
Aetiological group Number of patients
with satisfactory SEP
data (% with respect
to all those with
satisfactory SEPs)
Number of patients with
satisfactory CMCT data
(% with respect to all
those with satisfactory
CMCT)
Isolated
Idiopathic/Genetic
Early onset generalized
isolated dystonia.
No evidence of
structural or
degenerative pathology
17 (11.0)
(of whom 6
DYT1 positive)
22 (11.5)
(of whom 8 DYT1 positive)
Complex
Idiopathic/Genetic
Early onset generalized
dystonia with
associated features
(Normal cranial MRI).
No evidence of
structural or
degenerative pathology
16 (10.3)
(of whom 5 DYT11
positive and 1
TIFF1 positive)
21 (11.0)
(of whom 4 DYT11 positive
and 1 TIFF1 positive)
Acquired
non-degenerative
due to perinatal brain
injury (Cerebral Palsy)
70 (45.2) 82 (42.9)
Acquired
non-degenerative
due to metabolic
condition
16 (10.3) 19 (9.9)
Acquired
non-degenerative
due to other cause
29 (18.7) 35 (18.3)
Acquired
Degenerative due to
Neurodegeneration
with Brain Iron
Accumulation (NBIA) or
mitochondrial disease
7 (4.5) 12 (6.3)
Total 155 191
Only the patients with technically satisfactory data are included.
155/162 (96%) of children tested for SEPs had technically satisfactory data. 157/191
(82%) of children tested for CMCT had technically satisfactory data.
technically unsatisfactory, as in previous reports (6, 15) (see Flow
chart in Figure 1A).
SEPs were obtained from all four limbs, using stimulation
of the median nerve at the wrist and posterior tibial nerve
at the ankle. Upper limb SEPs were recorded over ipsilateral
Erb’s point, the 7th and 2nd cervical vertebra and contralateral
centro-parietal scalp overlying sensory cortex at C3′ and C4′
(2 cm posterior to C3 and C4). Posterior tibial nerve SEPs were
recorded over ipsilateral popliteal fossa and midline scalp at Cz′
(2 cm posterior to Cz) and, more recently (from October 2014
onwards), additionally using a Cz′-Cc derivation (18). The upper
lumbar components were recorded where possible (T12/L1—
iliac crest). Filter band-pass was 1–500Hz and the sampling
rate 2 kHz. At least two averages of 250 artifact-free trials were
recorded to determine reproducibility. The components were
labeled according to their polarity and peak-times in adults and
FIGURE 1 | Data flow charts (A) CMCT (B) SEP.
the data were compared with published pediatric norms (19–
21). Cortical potentials were classed as abnormal if they were
delayed (peak times greater than published mean for age-group
+ 2.5 standard deviations), absent or of abnormal waveform (i.e.,
clear time-locked cortical activity was present but waveforms
were poorly formed or broadened) (see Figure 1). Technically
unsatisfactory recordings were excluded from further analysis
(see Flow chart in Figure 1B).
For each individual, there was a maximum of 4 limbs of
SEP data and 4 limbs of CMCT data, but not all individuals
had satisfactory data recorded from all 4 limbs. To simplify the
analysis, a “binary coding” was assigned to the SEP and CMCT
data for each child. Thus, if CMCT to one or more limbs was
abnormal, that child was considered in the “abnormal CMCT”
group. Likewise, if the cortical SEP from one or more limbs
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was abnormal, that child was considered in the “abnormal SEP”
group, corresponding with previous reports (6).
MR examination was performed on an Achieva 1·5 Tesla MRI
system (Philips, Best, Netherlands), under general anesthesia.
Images were acquired using an 8-channel head coil, according
to the local “DBS protocol,” to include those sequences required
by the neurosurgeons for electrode targeting in the event that the
patient went forward for DBS surgery (6, 15). TheMRI scans were
interpreted by a consultant neuroradiologist and the findings
classified, for the purposes of this study, on the anatomical
location of abnormalities (6, 15) with the rationale to identify
abnormalities in the target nucleus (globus pallidus internus)
and to identify patterns of imaging abnormality which would be
expected to be associated with dysfunction of the Corticospinal
tract (Table S-1 and Figure S-2).
Neurosurgical Procedure
Surgery was performed under isofluorane general anesthesia, in
view of the young age of the children. Stereotactic MRI was
performed pre-operatively under anesthesia with a Leksell G
Frame in place to determine co-ordinates targeted in the postero-
latero-ventral GPi. Bilateral electrodes were implanted in each
case. The electrodes used are all Medtronic 3389 circumferential
electrodes: contacts 0.5mm apart and 1.5mm in length. Final
electrode placement was confirmed by post-operative stereotactic
CT scan, under the same general anesthetic, fused with the intra-
operative in-frame pre-surgical MRI. The pulse generator was
then inserted (Soletra and Kinetra until 2008, and Activa RC
pulse generators thereafter, Medtronic, Minneapolis, MN, USA).
Accuracy of electrode placement within our service has been
studied previously (22). Mean Euclidean distance between final
electrode tip position and target position was 2.2mm with no
difference in accuracy between isolated genetic/idiopathic and
acquired dystonia cases. No correlation was found between
outcome at 1 year and Euclidian distance between target and
actual position (22).
Analysis of Imaging and Neurophysiology Parameters
in Relation to Outcome
Of the 244 children, 133 (54.5%) went forward for DBS and
had 1-year outcome data available. All these children had
cranial MRI, 111 (83.4%) had satisfactory CMCT data and
77 (57.8%) had satisfactory SEP data (Figure 1) [Note SEP
recordings were incorporated into the assessment pathway more
recently than CMCT, hence the lower numbers (see Figure 1B)].
Baseline statistical analysis of these parameters in relation to
outcome was performed in SPSS, as per McClelland et al.
(6), to allow comparison with the previous report. Differences
between groups were investigated using Mann-Whitney test for
percentage change in BFMDRS-m (non-normally distributed
data) and independent samples t-tests for COPM scores
(normally distributed data) (see Supplementary Material).
The main purpose of the current report is to investigate
the potential application of a Machine Learning approach to
the prediction of outcome from DBS based on the following
parameters: sex, etiology, baseline severity, cranial MRI, CMCT,
and SEP. Data from all children proceeding to DBS and with
1-year outcome data (n = 133) were included in the Machine
Learning analysis, including initially those who had outcome
data, but in whom no satisfactory CMCT or SEP data was
available. For the purpose of theML analysis CMCTwas classified
as Normal/Abnormal/Not available (NA) and SEP was classified
as Normal/Abnormal/NA.
Machine Learning for Clinical Decision
Support
With the large increase in the amount of data that is now
collected, and increasing computational power, a large suite of
techniques [commonly termed as “Machine Learning” (ML)]
have been developed that have led to disruptive changes in a
wide variety of industries. Unlike other industries, adoption of
ML-based solutions in routine clinical practice is slow due to
the unique challenges of healthcare delivery. One such challenge
is the need for clinically interpretable algorithms. Many ML
techniques are black boxes which are not suitable, especially in
a clinical problem setting where existing evidence is sparse. It is
therefore important that any ML-based algorithm developed is
clinically interpretable. One of the most widely explored fields
within ML, and the one that is most relevant to clinical decision
support systems, is supervised learning.
Supervised Learning
Supervised learning uses previous examples with known outputs
(or labels) to determine the most optimal decision boundary
that can then be used to classify unseen data. This can best be
explained with the help of Figure 2A which shows two classes
(red crosses, and green circles) and the classification task is to
determine a decision boundary that can help identify if a new
case belongs to the red class or the green class. A linear classifier
will seek to determine a straight line that can best separate the
two classes. Mathematically, this is equivalent to finding the
values of α and β (through optimization using algorithms such
as gradient descent) of a linear equation (α(BR) + β(HR) ) that
leads to the most “optimal” classification. There are several ML-
based classification algorithms, each with their own optimality
criterion. Logistic regression (LR) is one of the most commonly
usedmethods for supervised classification. LR is generally simple,
easy to implement and interpretable. There are, however, two
drawbacks of using an LR-based classification in our case. Firstly,
it is a linear classifier, attempting to find a linear combination of
different predictors. The example in Figure 2 shows a situation
where a linear classifier will not be able to correctly classify
all cases as the separation between classes is non-linear. For
LR-based classification algorithms, such cases can be handled
by introducing new, non-linear features but this increases the
chances of over-fitting. Secondly, LR is not ideally suited to using
categorical features and requires techniques such as hot-encoding
(a machine learning technique that converts categorical features
into numerical values so that algorithms can work as intended,
but which may also increase the chances of overfitting) (23).
Decision Trees
Consequently, we propose using decision trees (DT) as the most
appropriate supervised classification method in our case. DTs
offer the possibility of combining features non-linearly thereby
enabling more complex boundaries to be drawn in the feature
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FIGURE 2 | Examples of decision boundaries and trees. (A) Linear decision boundary for classification, and the corresponding linear function representing the straight
line that separates the two classes. (B) Non-linear decision boundary achieved using a decision tree. (C) Decision tree corresponding to the decision boundary
shown in (B).
space. They also handle categorical features without the need for
any hot-encoding. Lastly, they are easily interpretable as every
decision can be precisely explained. The same scenario that was
introduced earlier in Figure 2A is shown to be handled more
elegantly with a decision tree-based classifier (Figure 2B) and the
corresponding decision tree is shown in Figure 2C.
In the current study, up to six possible clinical features (sex,
etiology, baseline severity, cranial MRI, CMCT, and SEP) were
investigated in order to determine the most useful combination
for predicting DBS prognosis (favorable or unfavorable).
Training, Validation, and Performance Evaluation
In this study, we used k-fold cross validation. This method is used
routinely as an internal validation technique where the data are
divided into k groups (each patient’s data is randomly allocated
in one of the k groups) and the algorithm is then trained on
the data from all groups except one. The trained algorithm is
then tested on the group that was not part of the training set
(i.e., out-of-sample testing). This process is repeated k times. This
effectively allows us to use all the data for testing while ensuring
that the same data is not used for both training and testing to
avoid over-fitting. The metrics we used to assess the performance
of the algorithms are based on True Positives (TP: number of
patients with favorable prognosis that are correctly predicted),
True Negatives (TN: number of patients with poor prognosis that
are correctly predicted), False Positives (FP: number of patients
with unfavorable DBS outcomes who were wrongly predicted to
have a favorable prognosis), and False Negatives (FN: number
of patients with favorable DBS outcomes who were wrongly
predicted to have an unfavorable prognosis) and these are:
Accuracy =
TP + TN
TP + TN + FP + FN
Sensitivity =
TP
TP + FN
Specificity =
TN
TN + FP
In order to benchmark the performance of the algorithms, we
defined amajority class classifier as the reference. Amajority class
classifier always outputs the class that is in majority irrespective
of the input. The accuracy of such a classifier will be equal to the
proportion of the majority class, and any classifier that results in
an accuracy greater than the majority class is deemed good. For
example, if 48 out of 80 patients show a positive response to a
treatment (without taking into account the variables in question),
then the majority (60%) of patients improve and the majority
class classifier performance is defined as 60% (i.e., one would
predict that 60% of patients would show a positive response). The
aim of the analysis is to test whether any additional classifiers
improve the accuracy of the outcome prediction above this
baseline level.
We also used receiver operating characteristics (ROC), where
applicable, to determine a range of sensitivity and specificity
values as the threshold (BFMDRS-m score in this case) for
decision making is changed. As the overall accuracy of any
decision tree on the test set (i.e., out-of-sample accuracy) is
dependent on the allocation of patient data in various groups
during k-fold cross validation, we used multiple iterations and
then computed the mean of the resulting accuracy, and where
applicable, we have also reported the error bounds (one standard
error) of our estimates.
Considering the six clinical feature variables (sex, etiology,
baseline severity, cranial MRI, CMCT and SEP), we investigated
all possible combinations of these six variables to construct
decision trees (DT) and evaluated the corresponding
performance with k-fold cross validation. In total, there were
(26 − 1) i.e., 63 different combinations that were investigated.
All the analysis was carried out in MATLAB (24). For
fitting a decision tree model, we used the “fitctree” provided in
MATLAB. The hyperparameters in the algorithm were learnt
using “Bayesian Optimization.”
RESULTS
Standard Feature-Outcome Associations
of Imaging and Neurophysiology
Parameters
The results of CMCT and SEP data for the cohort as a whole
are in keeping with the previously reported smaller dataset (6)
and are reported in the Supplementary Material. Of the 244
children, 133 went forward for DBS and had 1-year outcome data
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available. All these children had cranial MRI, 111 had satisfactory
CMCT data (compared with 89 in previous cohort) and 77 had
satisfactory SEP data (compared with 51 in previous cohort) (6).
Statistical analysis of these parameters in relation to outcome was
also concordant with the previously reported smaller dataset and
is shown in Figures S-3, S-4. The remainder of the results focus
on the ML analysis.
Machine Learning Analysis
Figure 3A shows the overall distribution of percentage
improvement in BFMDRS-m after 1 year follow-up across
the 133 patients. In literature pertaining to DBS outcomes, a
≥20% change in BFMDRS-m at 1 year has been reported as a
cut-off for defining improvement (25, 26), although this scale
was not developed for use in children (8) and is of limited use
in acquired dystonia or dyskinetic cerebral palsy (13, 27, 28).
In the current dataset, which is dominated by patients with
acquired dystonia, the majority of patients do not reach this level
of change. However, we initially investigated which DT leads to
the highest accuracy based on this criterion, to allow comparison
in the context of the wider literature.
Figure 3B shows the optimal DT that was determined. This
suggests that etiology alone can provide the highest accuracy
when determining whether DBS can lead to ≥20% change in
BFMDRS-m at 1 year. According to this DT, any patient who has
an isolated genetic or idiopathic dystonia or a complex genetic or
idiopathic dystonia (see Table 1) is likely to benefit from DBS. In
this case, the majority class classifier had an accuracy of 80.5%
(i.e., 80.5% of the patients will not achieve ≥20% change in
BFMDRS-m). Using the DT resulted in out-of-sample accuracy
of 85.5% (an improvement over the majority class classifier).
As noted above, there is already good evidence that individuals
with isolated genetic or idiopathic dystonias (previously termed
primary) are likely to show improvement with DBS, including
a recent meta-analysis of DBS for dystonia in children (8). The
area in which predictive factors are particularly needed, however,
is with respect to acquired dystonias, in whom the degree of
benefit is more variable between individuals and harder to predict
(8, 15, 29). Apart from a small study in 10 patients with dystonic-
dyskinetic cerebral palsy (28), the above 20% improvement cut-
off has not been validated in pediatric studies. Previous studies
have suggested that improvements in BFMDRS-m more modest
than 20%, are still beneficial to patients and their families (4,
13, 27, 30). Relatively small reductions in dystonia can bring
meaningful benefit in function and quality of life (see discussion
later on other scales).
Consequently, further investigation focused on the 96
acquired dystonia cases, and any improvement, defined as >0%
change in BFMDRS-m was considered as a positive outcome
while the remaining cases were considered as negative (other
thresholds were also investigated as described later). Themajority
class classifier for this analysis had an accuracy of 60.42% (i.e.,
58 of the 96 children with acquired dystonia proceeding to DBS
had a positive outcome by this definition). Figure 4A shows the
overall accuracy after investigating all 63 possible combinations
of clinical variables (sex, etiology, baseline severity, cranial MRI,
CMCT, and SEP) and a corresponding table listing the top 10
best performing combinations based on classifier accuracy. It
is worth noting that as the assigning of patients in k groups
during k-fold cross validation is random, the overall accuracy will
vary each time the k-fold cross validation procedure is repeated.
Figure 4A therefore shows the mean (over all iterations) and
Figure 4B lists the top 10 best performing combinations based
on mean accuracy. Looking at performances using individual
features, we can see that only a decision tree using CMCT or SEP
(as an individual feature) outperforms the majority class classifier
accuracy, yielding accuracies of 66.21 and 63.39%, respectively.
Because the performance of any decision tree depends on
which data samples are assigned in which folds (the smaller the
data size, the more likely it is to have results sensitive to which
folds data are assigned to), we decided to consider the top 10
best performing decision trees as opposed to picking a single
best performing tree. These 10 combinations performed fairly
similarly, and all have CMCT present as a feature. We can also
see baseline dystonia severity is the second most common feature
that most consistently appears (along with CMCT) in the top 10
best performing combinations. We therefore chose the decision
tree (index 36) that uses CMCT and baseline dystonia severity for
further analysis, for two reasons. Firstly, both CMCT and baseline
severity are the two features that appear the most consistently
in the top 10 best performing combinations. Secondly, baseline
severity is a continuous variable which then allowed us to
demonstrate how we could select a cut-off threshold and its
implication on sensitivity and specificity for personalized clinical
decision making.
The decision tree showed equivalent performance regardless
of the order in which the variables were included. For the
purposes of illustration, we used the following DT (Figure 5):
Assess child by CMCT. If CMCT is abnormal, DBS is less likely
to be effective at reducing dystonia. If CMCT is normal, assess
the child’s baseline BFMDRS-m to determine severity. If the
child’s condition is very severe (based on a specific cut-off chosen
automatically by the decision tree—see below), DBS is more likely
to be effective in reducing dystonia severity, as measured using
BFMDRS-m. For children with lower baseline severity (i.e., less
than the threshold identified automatically), DBS is less likely to
be effective in reducing dystonia, as measured using BFMDRS-m.
However, severity is a continuous variable, so what value
should be chosen as a cut-off? As the BFMDRS-m cut-off
used in the DT is varied, so will the resulting accuracy and
the likelihood of missing a positive effect. We consequently
devised a Monte Carlo simulation technique to help inform case-
specific decisions given patient, family and clinical preferences
and the current data (see Figure 5). Furthermore, we removed
all the cases where CMCT data were unsatisfactory (18 cases
out of the total of 96 cases with acquired dystonia) to remove
any potential bias in results (see Discussion). In the Monte
Carlo simulation, we sampled 100 cases (with substitution) from
the total pool of acquired dystonia patients (78 cases after
removing those who did not have CMCT available) for 1,000
times and computed the sensitivity and specificity for every
possible threshold of the BFMDRS-m in steps of 0.5. Figure 6A
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FIGURE 3 | Change in BFMDRS-m after 1 year and decision tree with 20% cutoff. (A) Distribution of % change in BFMDRS-m across all patients, with 20%
improvement marked by the red vertical line. (B) Decision tree based on cut-off of ≥20% improvement in BFMDRS-m, suggesting that DBS prognosis is favorable
when patients have genetic or idiopathic dystonia, and less favorable in cases with acquired dystonia.
FIGURE 4 | Decision tree performance and winning tree with cut-off ≥0% improvement in BFMDRS-m considering all possible combinations. (A) Out-of-sample
accuracy of decision trees investigating all possible combinations (63) for patients with acquired dystonia, reference accuracy corresponding to the percentage of
majority class, and decision trees based on single feature highlighted, suggesting that CMCT is the most informative feature. (B) The top 10 trees, based on accuracy,
with the index number associated with those in (A). Each possible combination in the table is binary-coded (1 indicating inclusion of the feature, and 0 indicating the
feature was not included in that combination) and the associated accuracy is reported (minimum leaf size of 10, i.e., the minimum number in end nodes, 100
iterations, 10 fold cross validation).
FIGURE 5 | Decision tree based on cut-off of ≥0% improvement in BFMDRS-m, that uses CMCT and baseline severity.
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FIGURE 6 | Variation in Decision tree performance with different cut-offs for baseline severity and ROC curve for baseline severity cut-off at point of transection of
specificity and sensitivity curves (A) Sensitivity and Specificity for different thresholds on BFMDRS-m at Node 2, after applying the decision tree based on CMCT and
BFMDRS-m on patients using Monte Carlo simulation. (B) Corresponding ROC curve which also shows the upper bound on sensitivity (88.16%), and lower bound on
specificity (29.49%) determined by the decision at Node 1 (i.e., CMCT abnormal).
FIGURE 7 | Overall decision tree to determine if DBS will have favorable prognosis.
shows the resulting sensitivity and specificity plotted with error
bars corresponding to one standard error and Figure 6B shows
the associated ROC curve. From the figure, it is obvious that
there is a trade-off between sensitivity and specificity. Some
working examples taking specific baseline severity cut-offs are
as follows:
(a) If one sets the cut-off baseline severity BMFDRS-m score
at 80, then patients with a baseline score of >80 would
be predicted by the DT to have favorable prognosis from
DBS while those with baseline score of <80 would be
predicted to have less favorable prognosis. The sensitivity
at this cut-off is 0.62, which means that 62% of those with
a positive outcome would be correctly identified by this
DT, while 38% of those who could have had a positive
outcome with DBS would be predicted wrongly to have a
poor outcome. The specificity at this cut-off is 0.64 which
means that 64% of those with a poor outcome would be
correctly identified by the DT as having a poor prognosis
(true negatives), whereas 36% of children predicted to have a
good outcome by the DTwould actually have a poor outcome
(false positives).
(b) If one sets the cut-off baseline severity BMFDRS-m score
at 100 then patients with a baseline score of >100 would
be predicted by the DT to have favorable prognosis from
DBS while those with baseline score of <100 would be
predicted to have less favorable prognosis. The specificity
at this cut-off is 0.78, which means that 78% of those
predicted to have a positive outcome would do so and
there would be fewer (22%) false positives. However,
the sensitivity at this cut-off is 0.28, which means that
only 28% of those with a positive outcome would be
correctly identified by this DT and 72% of those who
could have benefitted would be predicted wrongly to have a
poor prognosis.
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FIGURE 8 | Decision tree performance and winning tree with cut-off ≥0% improvement in BFMDRS-m considering all possible combinations except CMCT. (A)
Out-of-sample accuracy of decision trees investigating all possible combinations (31) for patients with acquired dystonia, reference accuracy (55.56%) corresponding
to the percentage of majority class (based on the 54 patients with SEP data), and decision trees based on single feature highlighted. (B) The top three trees, based on
accuracy, with the index number associated with those in (A). Each possible combination in the table is binary-coded (1 indicating inclusion of the feature, and 0
indicating the feature was not included in that combination) and the associated accuracy is reported. (C) Overall decision tree found for cases with acquired dystonia
when CMCT is presumed unavailable.
(c) If one sets the cut-off baseline severity BMFDRS-m score
at 60 then patients with a baseline score of >60 would be
predicted by the DT to have favorable prognosis from DBS
while those with baseline score of<60 would be predicted to
have less favorable prognosis. The sensitivity at this cut-off is
around 0.75, which means that 75% of those with a positive
outcome would be correctly identified by this DT, with fewer
(25%) false negatives (those who could have had a positive
outcomewithDBS but were predicted wrongly to have a poor
outcome). The trade-off is that the specificity at this cut-off is
around 0.45, which means that only 45% of those predicted
to have a positive outcome would do so and there would be
more (55%) false positives.
Increasing the cut-off of BFMDRS-m makes it less likely that
a patient will get a positive prognosis leading to increased
specificity at the cost of decreased sensitivity. Thus, if the patient,
family and clinician together feel that they would rather not miss
the possibility of a positive surgical outcome, they could opt for a
BFMDRS-m cut-off to the left, and the corresponding sensitivity
and specificity of the outcome prediction considered. Conversely,
if the patient, family and clinician together take a more risk
adverse view and want to be more certain of the predicted
outcome then the BFMDRS-m cut-off might be taken to be
to the right, and the corresponding sensitivity and specificity
considered in coming to a final decision.
In summary, the range of sensitivity/specificity in the figure
will vary according to threshold selected for BFMDRS-m at
the second node of the decision tree. However, the decision at
node 1 (whether CMCT is normal or abnormal) results in the
red and green bounds shown in Figure 6B. On average, there
were 11.84% of patients who, despite favorable DBS outcome,
had an abnormal CMCT. If this decision tree was to be used
for clinical decision making, then 11.84% of cases who could
have benefited from DBS would instead be deemed to have
a poor DBS prognosis. As sensitivity captures the proportion
of patients with favorable DBS prognosis who are correctly
identified, missing these 11.84% cases results in the upper bound
on sensitivity shown in red. However, at the same time, 29.49% of
patients with unfavorable DBS outcomes are correctly identified
at node 1. As specificity captures the accuracy of identifying the
proportion of people with unfavorable DBS outcomes, there were
Frontiers in Neurology | www.frontiersin.org 9 August 2020 | Volume 11 | Article 825
Shah et al. Childhood-Dystonia: Data-Driven DBS Prognosis
29.49% of such patients with an abnormal CMCT (shown by
the green bound on specificity) and hence would be correctly
deemed to have an unfavorable DBS prognosis (based on
these criteria).
Figure 7 proposes the overall decision tree that combines the
analysis of the whole population (when using a threshold of
≥20% change in BFMDRS-m as improvement) and the analysis
carried out on cases with acquired dystonia (when using a
threshold>0% change in BFMDRS-m as improvement).
Since TMS is not available in all centers and, as we report
above, is sometimes not performed for clinical reasons, or cannot
be completed, we also looked at the data from the viewpoint of
CMCT not being done. There were 54 patients with acquired
dystonia who had SEP performed. We analyzed this cohort
of 54 patients using a similar approach as before, testing all
possible combinations (but without CMCT this time). Figure 8A
shows the overall accuracy after investigating all 31 possible
combinations of clinical variables (sex, etiology, baseline severity,
cranial MRI, and SEP). Compared with Figure 4, fewer DTs are
seen to exceed the majority class classifier. However, several trees
did lead to improved accuracy and the top 3 best performing
combinations are listed in Figure 8B. These results suggest that
SEP is an important factor for predicting DBS prognosis for
a child with acquired dystonia in cases where CMCT is not
present. However, no other feature (cranial MRI, sex, etiology,
and baseline severity) provides any further predictive value in
this analysis. Figure 8C shows the resulting decision tree in cases
where CMCT is not available.
Furthermore, given that inter-rater reliability for scoring
BFMDRS-m is not 100%, we also investigated the impact of
choosing different thresholds of the BFMDRS-m to define
positive and negative surgical outcomes in acquired dystonia.
Table 2 summarizes the number of cases with positive and
negative outcomes, and features that appeared in the best
performing models (i.e., those that appeared in >5 models out
of the top 10 models). While the results vary due to the limited
number of cases, CMCT appears as one of the best features for all
possible thresholds of BFMDRS-m that were investigated.
Lastly, given the limitations of using BFMDRS-m in a
pediatric population (8), especially in acquired dystonia and
dyskinetic cerebral palsy (13, 27, 28), we also investigated the
use of COPM to separate positive DBS outcomes from negative
outcomes. The number of patients who had COPM data was
less than in the original group of patients with post-operative
results (96 vs. 133). A change in COPM score of≥2 is considered
clinically significant (13), so in our preliminary analysis, we used
this threshold to separate positive from negative DBS outcomes.
However, using these data, we were not able to find any decision
tree that performed better than the majority class classifier.
DISCUSSION
We investigated the prognostic value of six key pre-surgical
clinical features (sex, etiology, baseline severity, cranial MRI,
CMCT, and SEP) in a cohort of 133 children progressing to
DBS for dystonia. Concurring with previous reports, the clearest
TABLE 2 | Variation of number of positive/negative cases in acquired dystonia,
and the top features (those that appear in >5 top 10 models) as the threshold on
BFMDRS-m to define improvement/no improvement is varied.
Threshold on Improved Not Improved Best features (i.e.,
% change in (%) (%) appeared >5
BFMDRS-m models out of the
top 10 models)
0 58 (60.4) 38 (39.6) CMCT, Baseline Severity
1 58 (60.4) 38 (39.6) CMCT, Baseline Severity
2 52 (54.2) 44 (45.8) CMCT, Etiology
3 48 (50.0) 48 (50.0) CMCT
4 45 (46.9) 51 (53.1) CMCT, Baseline Severity
5 41 (42.7) 55 (57.3) CMCT, Sex
>5 Performance degradation (not enough models that perform better
than majority class classifier)
distinction in outcome was between those children with genetic
or idiopathic dystonias, compared with acquired dystonias.
Focusing on the 96 children with acquired dystonia, we found
that CMCT is the feature with greatest value in predicting
improvement after surgery, and where this test is not available or
technically unsatisfactory, then SEPs offer an alternative source
of prognostic information. Based on these findings we suggest
a data-driven, clinically useful tool as an illustration of how
ML techniques could support the decision whether or not to
proceed to DBS in young people with dystonia (Figures 7, 8).
The decision support tool is the product of decision tree analysis,
and the sensitivity and specificity of the predictions underpinning
the tool are specified. In addition, we suggest a novel method
whereby decisions can accommodate case-specific preferences.
Such ML-based decision support tools should be revised as
necessary as more data become available, and we emphasize that
our primary goal here is to use the present cohort to illustrate
how ML could support clinical decision making, rather than
producing a definitive final decision tree.
Standard Feature-Outcome Associations
Standard feature-outcome associations in our cohort (reported
in details in Supplementary Material) confirmed and extended
previously published data showing that patients with abnormal
CMCT and/or abnormal SEP show less reduction in dystonia
(measured using BFMDRS-m) with pallidal DBS than those
without such abnormalities (6). These conclusions are derived
from contrasts of the outcome between groups with and without
a given feature, or from correlations between features and
outcome. However, feature-outcome associations do not provide
a measure of the sensitivity and specificity of any derived
prediction, nor, in their simplest form, do they lend themselves
to the consideration of combinations of features.
Decision Tree Analysis
We were particularly interested in using this cohort to explore
how decision trees can provide clinically useful decision support
tools able to inform surgical decisions while at the same time
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providing estimates of the sensitivity and specificity of the
underlying outcome predictions. In effect, these estimates allow
the clinician to weigh the significance of each step in the decision
tree. The first clear “decision point” in our decision tree analysis
is whether the patient has an idiopathic or genetic dystonia
vs. an acquired dystonia, as DBS for the former categories
is likely to have a favorable outcome. This decision point is
consistent with both the literature (see Introduction) and our
own feature-outcome association analyses. The second “decision
point” suggests that the CMCTs and baseline BFMDRS-m can be
used in combination to help decide on whether DBS may have
a favorable outcome in patients with acquired dystonia. In this
analysis, a normal CMCT and more severe BFMDRS-m suggest
that DBS is, on balance, likely to have a positive outcome in
acquired dystonia.
However, CMCT is not always available. TMS is not
performed in some centers and, even when available it is
sometimes contra-indicated, for example in the presence of a
cochlear implant. Furthermore, despite best efforts, it may be
attempted but without successful data acquisition as a small
number of patients do not tolerate the stimulus, especially
children with high thresholds. Our ML analyses indicate that
where CMCT is not available, SEP alone is still helpful in
improving accuracy of outcome prediction, and this forms the
basis for an alternative decision tree where SEP status provides
the basis for the second decision point. The feature-outcome
association analyses previously performed by McClelland et al.
(6) and extended here were also able to identify CMCT and
SEPs as having predictive value, helping to again validate the DT
approach. However, they were not able to assess the predictive
value of combined features.
The specific etiology of acquired cases, baseline severity
(alone), the results of cranial MRI, and gender were of no
additional value at this stage, in deciding whether surgery might
be worthwhile, and did not improve upon the majority class
classifier when considered in isolation (Note this does not
diminish the role of imaging. Cranial MRI already plays an
important role in the classification of dystonia as acquired or not,
by demonstrating whether structural or degenerative changes are
present). BFMDRS-m severity only improved the accuracy with
which outcome could be predicted in acquired dystonia when
considered in combination with CMCTs, but none of the other
non-electrophysiological attributes afforded additional predictive
value in combination. Baseline severity did not improve the
accuracy of prediction in the smaller analysis performed to reflect
the situation where CMCT was not available (Figure 8). The
reason for this is not clear, but could be a reflection of the smaller
numbers in this analysis.
Previous literature reporting the association between disease
severity and DBS outcomes shows conflicting results (7, 31, 32).
Moro et al. (31) in a meta-analysis of 523 isolated inherited or
idiopathic cases undergoing DBS surgery reported a multivariate
meta-regression of absolute BFMDRS-m scores indicating that
higher BFMDRS motor and disability scores before surgery,
together with younger age at time of surgery, were the main
factors associated with significantly better DBS outcomes at the
latest follow-up. In contrast, the study by Badhiwala et al. (7)
reported that in 125 patients with acquired dystonia (derived
from a systematic review and individual patient data meta-
analysis), a higher disease severity was associated with poor
DBS outcomes. It is important to highlight the key differences
between our study and the work by Badhiwala et al. (7) that
may explain this difference. Firstly, their work derived latent
variables (each such variable is a combination of several features
with different weights, estimated in a data-driven manner) and
did not assess the contribution of individual features. Secondly,
it is possible that the difference in proportion of children with
neurodegenerative conditions between our study (<10%) and
their study (∼40%) may explain this discrepancy (patients with
neurodegenerative conditions often have higher baseline severity
scores, but will inevitably worsen with time despite an initial
response to DBS). Lastly, the latent variable that Badhiwala et al.
(7) found to suggest that higher baseline severity leads to poorer
DBS outcomes was not only dependent on baseline severity,
but several other features (such as age at onset, age at surgery,
duration and proportion of life with dystonia). In our case,
however, the DT we derived suggests that only in patients with
normal CMCT are children with low baseline severity likely to
have less favorable DBS outcomes.
Some previous reports (7, 8, 31) have looked at the potential
role of age at onset of dystonia or proportion of life lived with
dystonia as potential predictive factors for DBS outcome. Age at
onset and proportion of life lived with dystonia are inextricably
linked with etiology (e.g., those with dystonic cerebral palsy,
the largest sub-group of acquired dystonia, have onset in the
perinatal period and have therefore spent virtually the whole
of their lives with dystonia). These parameters were therefore
not chosen for the present analysis because of this potential
confound, especially since our work focused on patients with
childhood-acquired dystonia.
Unlike the basic feature-outcome associations, the DT analysis
requires a threshold to be set for outcome, above which the
DT considers a good outcome/favorable prognosis and below
which the DT considers a poor outcome/less favorable prognosis.
Choosing a threshold is not straightforward, particularly using
the BFMDRS-m, with its inherent limitations in this population.
A level of 20% improvement in BFMDRS-m has been used in
several previous studies, but clinically important changes are
still observed in many young people with acquired dystonia,
even where this level is not achieved (13, 27, 28, 30). Day to
day fluctuations in performance on this scale within a given
individual are noted and inter-rater reliability is a further
important consideration. Within our own service, inter-rater
reliability is ∼6–10% (Gimeno unpublished observations). A
cut-off point will therefore always, in reality, reflect a range of
values and this caveat should be kept in mind when interpreting
the findings. The threshold of 0 chosen here has the benefit
of showing negative changes (worsening of BFMDRS-m) as
a poor outcome and positive changes (any improvement in
BFMDRS-m) as a good outcome, which is visually easy to
conceptualize. Adjusting the cut-off threshold between 0 and 5%
in the current analysis produced comparable results in terms
of which factors improved the accuracy above the majority
class classifier. Above this level there were insufficient cases
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classified as having a positive outcome for the ML algorithm to
work effectively.
An alternative outcome measure, the COPM, was also
assessed in the current study. Patients with abnormal SEPs
show a trend towards less benefit in terms of functional
goal achievement (COPM) compared with those with normal
SEPs (see Supplementary Material). Applying the current DT
methods using a threshold of ≥2 point improvement in COPM
score did not identify any parameter that performed better than
the majority class classifier. The reasons for this are uncertain
but could include the smaller number of cases for whom COPM
data was available, or the higher proportion of cases that improve
with this threshold i.e., there may be insufficient numbers of
cases in the “no improvement” group for the ML algorithm to
work effectively. The findings could also reflect the nature of
the goal-setting process, which takes into account all the clinical
assessments in setting realistic and achievable goals. Further
objective, blind-rated outcomemeasures are therefore needed for
future work.
Another consideration when assessing outcomes is the
potential impact of GPi DBS on non-motor functions. We
have evaluated cognitive abilities before and after DBS across
the etiological spectrum in childhood dystonia and found
overall no adverse consequences of GPi DBS in genetic (33) or
acquired dystonias (including dystonic cerebral palsy) (34) or
neurodegeneration with brain iron accumulation (NBIA) (35).
Recent work also demonstrates the benefit of DBS in reducing
pain in children with dystonia and dystonic cerebral palsy
(36). Further work is currently ongoing to assess non-motor
functioning pre- and post-DBS in more detail.
Study Strengths
Previous work has shown a significant correlation between the
outcome of neurophysiological tests, CMCT and SEP, and change
in BFMDRS-m (and for SEP, the change in COPM scores)
following DBS (6). However, it was not obvious from that study
how much value there might be in basing a decision about
DBS surgery on CMCT and SEP results (37). This analysis
extends the previous work by usingMachine Learning techniques
to incorporate these features into a clinical decision support
tool, where the recommendations can be assessed through the
sensitivity and specificity of the predictions underscoring each
step. In addition, a larger sample of patients was available for
the current analysis. The study shows how the DT methodology
can be used to assess combinations of features (e.g., baseline
severity, CMCT, etc.) and convert them into a practical tool that
can provide a guide to prognosis for DBS. As these results are
based on existing data they therefore represent an evidence-based
approach to clinical decision making. This work also quantifies
the extent of error to be expected if the proposed decision tree is
used, in terms of sensitivity and specificity. It therefore identifies
which features should be included in clinical decision making
and provides a methodological framework to systematically
explore contributions from multiple features. An evidence-based
DT and sensitivity/specificity curve might also potentially assist
clinical teams when counseling patients and families about
expected benefit from DBS. It can therefore help with managing
expectations and makes steps toward providing a personalized
prognosis, sensitivity and specificity. Indeed, we demonstrate
how case-specific preferences, such as the strong wish not to
miss the possibility of a positive outcome, can be accommodated
within this framework. Lastly, the algorithm developed is highly
interpretable and accessible to health care professionals.
Study Limitations
Firstly, our decision trees are based on numbers of patients that
are relatively small for typical machine learning applications that
have previously been shown to work well in healthcare with large
datasets (38). Nevertheless, the DT method was able to pick out
the features that were most predictive of outcome and produce
a tree that makes clinical sense, and which is concordant with
other analyses. Secondly, the data are all from a single center
and we were only able to do an internal validation with k-fold
cross validation technique. It is thus possible that the results
presented in this work may be subject to overfitting and may
not generalize well. Third, this study was a retrospective study
and the clinical decision to proceed or not to DBS may have
already been influenced by theoretical assumptions relating to
neurophysiological results (6) leading to a possible circularity.
A further factor is that the analysis here is based on 1-year
outcome data. Improvements following DBS continue beyond
1 year and even up to 5 years, so future work is needed to
assess whether the DTs developed here will still help in predicting
these later improvements. Lastly, the outcomes in this study
were based primarily on changes in the BFMDRS-m. This scale
has significant limitations for childhood-onset dystonia and
acquired dystonia and is not sensitive to some changes which
are still meaningful for young people and their families (13, 27).
We are working towards obtaining data with other objective
outcome scales, but numbers are not yet sufficient to apply a ML
method to these data. Preliminary data (Gimeno andMcClelland,
unpublished observations) indicate that patients with abnormal
neurophysiological tests show less benefit from DBS as measured
using other such scales, but this requires confirmation by further
analysis with larger subject numbers.
CONCLUSION
This study is the first exploration of how a ML-based approach
could be used to predict potential benefit from DBS in
children with dystonia and to aid clinical decision making and
counseling of families about expected outcome. Although ML
methods generally excel in very large datasets, the Decision
Tree methodology provides a data-driven, highly interpretable,
example decision support tool even in our modestly sized cohort.
The key finding is that neurophysiological parameters can help
to predict the outcome of DBS. We encourage other centers
to introduce neurophysiological measures to their assessment
pathways and to collect data to facilitate future multi-center
evaluation of these potential predictive markers and the testing
of the illustrative decision support tools presented here. Future
work will also consider additional outcomemeasures and thereby
broaden DT-based decision support tools.
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